GlassScriptPhysician profile
Sarah Belliotti
NPI 1801258769
$6,013.74
in general payments reported to CMS, 2019-2025
40 companies · $939 in 2025
The $939 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $592 · 2021: $961 · 2022: $1,456 · 2023: $885 · 2024: $1,181 · 2025: $939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,004.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $610.22 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $561.44 | 2020-2024 | Xifaxan |
| Abbvie INC. | $520.19 | 2020-2023 | Lo Loestrin Fe, Orilissa |
| Organon LLC | $383.01 | 2022-2025 | Jada System, Nexplanon |
| Medical Device Business Services, INC. | $325.00 | 2020 | |
| Astellas Pharma US INC | $317.13 | 2022-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $316.18 | 2022-2025 | Slynd |
| Therapeuticsmd, INC. | $284.20 | 2021-2022 | |
| Daiichi Sankyo INC. | $255.03 | 2020-2024 | Injectafer |
| Exact Sciences Corporation | $219.50 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $200.04 | 2020-2025 | |
| Agile Therapeutics, INC. | $197.46 | 2021-2024 | Twirla |
| Sumitomo Pharma America, INC. | $171.50 | 2023-2025 | Myfembree |
| Amgen INC. | $162.39 | 2020-2024 | Prolia, Evenity |
| Novo Nordisk INC | $152.52 | 2020-2025 | Wegovy |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $117.88 | 2022-2024 | Contrave, Onzetra Xsail |
| Biogen, INC. | $105.99 | 2024-2025 | Zurzuvae |
| Gilead Sciences, INC. | $101.13 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $96.04 | 2021-2022 | |
| Shield Therapeutics INC | $95.84 | 2023-2025 | Accrufer |
| Myovant Sciences INC. | $90.76 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.47 | 2022-2024 | |
| Medela LLC | $74.91 | 2022 | |
| Coopersurgical, INC. | $72.19 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Millicent US INC | $65.95 | 2025 | Intrarosa, Femlyv |
| Dexcom, INC. | $53.69 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $50.19 | 2024 | Gardasil 9, Gardasil |
| Avion Pharmaceuticals | $49.63 | 2020-2021 | |
| Evofem Biosciences, INC. | $44.90 | 2020-2022 | |
| Lilly USA, LLC | $34.87 | 2020-2024 | Jardiance, Zepbound |
| Biohaven Pharmaceutical Holding Company LTD. | $31.97 | 2022 | |
| Seqirus USA INC | $23.93 | 2025 | Flucelvax |
| Hologic Sales and Service, LLC | $23.32 | 2024 | Aptima |
| Ascend Therapeutics US, LLC | $20.70 | 2022 | |
| Roche Diagnostics Corporation | $19.99 | 2021 | |
| Si-Bone, INC. | $19.49 | 2023 | |
| Covidien LP | $19.10 | 2020 | |
| Idorsia Pharmaceuticals US INC | $14.16 | 2023 | Quviviq |
| Meditrina | $14.08 | 2021 | |
| Urovant Sciences INC | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Belliotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.